Percutaneous Coronary Angioplasty in Patients with Cancer: Clinical Challenges and Management Strategies

Mamas

Abstract

<jats:p>The number of cancer survivors in the United States is projected to increase by 31% by 2030. With advances in early screening, diagnosis and therapeutic strategies, a steadily increasing number of patients are surviving cancer. Coronary artery disease (CAD) is now one of the leading causes of death amongst cancer survivors, with the latter group of patients having a higher risk of CAD compared to the general population. Our review covers a range of specific challenges faced by doctors when considering percutaneous coronary interventions (PCI) in cancer patients; clinical outcomes in cancer patients undergoing PCI, as well as some important technical considerations to be made when making decisions regarding the management strategy in this special population of patients.</jats:p>

• Acceptance Date: Aug 23, 2022
• Publication Date: Aug 25, 2022
• Journal: Journal of Personalized Medicine
• Publisher: MDPI
• Pages: 1372 - 1372
• DOI: https://doi.org/10.3390/jpm12091372
• Keywords: cancer; percutaneous coronary angioplasty; coronary artery disease; outcome
• Publisher URL: https://www.mdpi.com/2075-4426/12/9/1372